Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents

Oncogene, Published online: 24 January 2020; doi:10.1038/s41388-020-1163-1Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents

https://www.nature.com/articles/s41388-020-1163-1

Source: Oncogene - January 23, 2020 Category: Cancer & Oncology Authors: Constantinos G. Broustas Axel J. Duval Kunal R. Chaudhary Richard A. Friedman Renu K. Virk Howard B. Lieberman Source Type: research

More News: Cancer | Cancer & Oncology | Gastroschisis Repair | Prostate Cancer